I can see further development of the ICON partnership that would provide a stake in Lympro or maybe exclusivity outside US. I really don't know if there is another player in Big Pharma or Diagnostics circling here but I bet they are very keen on this product. All I know is that ICON is involved and could get built out. AMBS is acting like they have money coming with all the hiring and they need money to push other programs. So, a year is way too far out in my opinion.